Coverage
-
June 03, 2015
A Pennsylvania federal judge allowed most of a False Claims Act case accusing Cephalon Inc. of a kickback scheme involving off-label drug marketing to continue Wednesday, saying the whistleblower had pled sufficient facts to proceed to discovery.
3 other articles on this case.
View all »